ASX Share rice
Tue 04 Aug 2020 - 03:35:pm (Sydney)

OSP Share Price

OSPREY MEDICAL INCOSPHealth Care Equipment & Services

OSP Company Information

Name:

Osprey Medical, Inc

Sector:

Healthcare

Industry:

Medical Devices

Address:

5600 Rowland Road Minnetonka MN United States 55343

Phone:

952 955 8230

Pres, CEO & Exec. Director:

Mr. Michael McCormick

Co-Founder:

Dr. J. Edward Shapland

VP of Fin. & CFO:

Ms. Nancy Ness

VP of Operations & IT:

Mr. Vic Fabano

VP of Regulatory Affairs, Compliance & Quality:

Ms. Melanie Hess

Company Overview:

Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies. The company focuses on protecting patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures in the United States and internationally. It offers AVERT, AVERT Plus, DyeVert NG, DyeVert Plus System, and DyeVert Plus EZ Systems, which are used to reduce contrast injected into patients during standard cardiovascular and peripheral procedures. The company was incorporated in 2005 and is headquartered in Minnetonka, Minnesota.

OSP Share Price Information

Shares Issued:

3B

Market Capitalisation:

$101.92M

Revenue (TTM):

$3.67M

Revenue Per Share (TTM):

$0.01

Earnings per Share:

$-0.045

Operating Margin (TTM):

$-4.98

Return On Assets (TTM):

$-0.59

Return On Equity (TTM):

$-1.08

Quarterly Revenue Growth (YOY):

0.383

Gross Profit(TTM):

$1.90M

Diluted Earnings Per Share (TTM):

$-0.042

OSP CashFlow Statement

CashFlow Date:

2019-12-31

Investments:

$-154,842.99

Change To Liabilities:

$218.50K

Total Cashflow From Investing Activities:

$-108,483

Net Income:

$-25,773,389.95

Total Cash From Operating Activities:

$-16,866,587

Depreciation:

$278.07K

Change To Inventory:

$-166,027

Change To Account Receivables:

$-72,278

Capital Expenditures:

$154.84K

OSP Income Statement

Income Date:

2019-12-31

Income Before Tax:

$-25,787,339.42

Net Income:

$-25,773,389.95

Gross Profit:

$2.71M

Operating Income:

$-26,035,598.06

Income Tax Expense:

$9.77K

Total Revenue:

$5.23M

Total Operating Expenses:

$28.74M

Cost Of Revenue:

$2.52M

OSP Balance Sheet

Balance Sheet Date:

2019-12-31

Intangible Assets:

$101.07K

Total Liabilities:

$3.91M

Total Stockholder Equity:

$11.53M

Other Current Liabilities:

$268.79K

Total Assets:

$15.44M

Common Stock:

$21.59K

Retained Earnings:

$-163,909,894.38

Other Assets:

$12.25K

Cash:

$11.81M

Total Current Liabilities:

$3.36M

Property - Plant & Equipment:

$0.96M

Net Tangible Assets:

$8.01M

Total Current Assets:

$13.96M

Net Receivables:

$663.59K

Short-Term Investments:

$1.48M

Inventory:

$1.34M

Accounts Payable:

$1.56M

Non Currrent Assets (Other):

$17.49K

Short-Term Investments:

$1.48

Non Current Liabilities (Other):

$548.81K

Non Current Liabilities Total:

$548.81K

OSP Share Price History

OSP News

30 Jul, 2020
GE Healthcare and Osprey Medical Inc. (ASX:OSP) (Osprey) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey. Osprey’s DyeVert™ contrast minimization devices, complemented by GE Healthcare's range of iodinated x-ray contrast media, offer healthcare professionals a technology platform to address the rising problem of Acute Kidney Injury (AKI) following interventional coronary angiograms in patients with Chronic Kidney Disease (CKD).
14 Apr, 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
15 Jan, 2020
Long term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic...
04 Oct, 2019
Just because a business does not make any money, does not mean that the stock will go down. For example, although...